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In the last decade the sensitivity and specificity of 
contrast enhanced ultrasonography (CEUS) has greatly 
improved due to the development of more sophisticated 
ultrasonographic equipment, the introduction of second-
generation contrast agents, and the development of dedi-
cated software able to perform quantitative analysis [1]. 
Therefore, nowadays CEUS is established as a significant 
advancement in imaging and an effective technique with 
several clinical indications, especially for liver pathol-
ogy as reported also in EFSUMB guidelines published in 
2012 [2]. Apart from liver indications, CEUS has proved 
to be effective in several other fields [1,3] so that in 2011 
EFSUMB reported their indications and recommenda-
tions for non-liver applications. These recommendations 
are based on comprehensive literature surveys including 
results from prospective clinical trials [4]. 
Among CEUS vascular indications related to ab-
dominal aorta diseases were: aortic dissection, vascular 
stenosis, complications after vascular intervention, ab-
dominal aortic aneurysm (AAA), inflammatory AAA, 
and endoleaks.
The most established recommendation was the detec-
tion, characterization, and follow up of endoleaks after 
AAA repair. In fact, CEUS is mainly employed in the 
assessment of abdominal vascular diseases to support the 
diagnosis of AAA and the evaluation of post operation 
complications.
Nowadays the surgeons prefer to treat AAA by us-
ing EVAR (Endovascular Aneurysm Repair) and not 
by performing traditional surgery which is more in-
vasive and aggressive and  also incurs hospitalization 
and early mortality. The most frequent complication 
of EVAR is the endoleak, the incomplete exclusion of 
aneurismatic sac from the arterial circulation which 
can be classified in 5 types according to the Society 
for Vascular Surgery and the American Association for 
Vascular Surgery. In 10-45% of cases such complica-
tions can be associated with a dilation of the aneurysm 
sac and rupture [5,6].
At the moment, CT angiography (CTA) is the refer-
ence diagnostic method, due to its wide availability, diag-
nostic value, acquisition speed, resolution, and uniform-
ity of protocols [7]. However, it is an expensive method, 
uses ionizing radiation and potentially allergenic and ne-
phrotoxic contrast agents. 
As reported in literature, some valid alternatives 
to CT are CEUS and magnetic resonance angiography 
(MRA) [8,9] but there is no consensus with regard  to the 
optimal work-up with diagnostic imaging modalities in 
postEVAR surveillance [10]. CEUS could represent the 
ideal imaging modality to follow up EVAR.
The ideal imaging modality should be inexpensive, re-
peatable, safe, and accurate [11]. CEUS is cheaper than 
CTA, uses ultrasound, not ionizing radiation, and em-
ploys second generation contrast agents without nephro-
toxic risks. It is safe and repeatable. Currently, in literature 
CEUS has given promising results for the identification 
of endoleaks and their correct classification [12]. Several 
authors have pointed out the usefulness of CEUS because 
it seems to identify and characterize endoleaks better 
than CTA, with an analysis of velocity and flow direction 
[13,14]. Moreover, CEUS enhancement quantification 
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with Time-Intensity Curve (TIC) provides additional ac-
curacy [15].
Conversely, CEUS still presents some clear limita-
tions, especially if  excess weight and meteorism are as-
sociated. Of particular note are also extensive wall calci-
fication and subcutaneous emphysema after intervention, 
or limited examination windows [4].
Therefore, each imaging modality has advantages 
and disadvantages that should be considered when devel-
oping a surveillance program. CEUS offers several ad-
vantages and limitations compared to CT, already men-
tioned. CTA is depicted by most as the pivotal imaging 
modality, while others consider CTA as unnecessary and 
expensive. MRA seems to offer better accuracy, but with 
higher costs and less availability [16].
Recently, a combined CEUS, color Doppler (CD) US, 
and CTA based protocol, that entails a base-line CTA at 
3 months and 1 year post-EVAR, followed by periodic 
CDUS and use of 3D CEUS when a suspicious finding 
is detected, while MRA is  performed in cases evidencing 
contraindications to CTA or in suspected endotension [10].
In a single case report, the authors reported an endo-
vascular aortic repair in a patient with an asymptomatic 
infrarenal AAA and renal insufficiency. The precise 
placement of the stent-graft was performed with CEUS 
and intraprocedural angiographic fluoroscopy without 
the use of any nephrotoxic contrast media [17]. Intraop-
erative CEUS-assisted EVAR in patients with infrarenal 
AAA was reported to represent a new option for the visu-
alization of aorto-iliac segments required as proximal or 
distal fixation zones and the identification of endoleaks, 
especially in those patients with contraindications for us-
age of iodine-containing contrast agents [18].
In a recently published review, Zimmerman et al 
summarized that CEUS is increasingly used and enables 
a quick, non-invasive follow-up examination for patient 
after EVAR. In addition, interventions such as therapy 
for endoleaks may be executed using ultrasound. Initial 
experience with CEUS-guided aortic stenting shows that 
the amount of contrast media as well as X-ray time may 
be reduced [19]. 
In conclusion, CEUS in the pre-, intra- and post-
EVAR surveillance is a safe and effective modality and in 
a well planned surveillance protocol it should be integrat-
ed into institutional protocols for EVAR surveillance in 
order to avoid the nephrotoxicity of contrast agents, the 
radiation and cost burden of repeated CTA-s in patients.
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